Packaging
Pfeiffer invests EUR 12 million in new logistics and technology centres
Wednesday 22. April 2009 - Extensive pharmaceutical division building programme in Germany focuses on current and future customer needs
Pfeiffer, a leading manufacturer of pharmaceutical pumps, is investing EUR 12 million in a new building project at its main manufacturing plant in Eigeltingen, Germany. A logistics centre and a new technical centre, covering a combined floor area of over 6,500 m², will both go into full operation in 2009. The logistics centre incorporates high bay racking, dedicated delivery and dispatch areas, plus a state-of-the-art packaging facility. In the technical centre, tools will be built, tested, maintained and repaired by the on-site experts. The new premises enable optimal process efficiency, allowing Pfeiffer to meet customer needs in an increasingly competitive, highly regulated market environment.
Multiple benefits
The increased capacity and operational efficiency of the new logistics centre, in use since January 2009, translates directly into measurable benefits for staff and customers. Its spacious architecture, integrating maximum daylight, provides a modern, ecologically responsible working environment. Excellent hygienic conditions, including plastic palettes, the total elimination of cardboard, and air screens preventing contamination from the integrated loading bays, bring clear advantages to customers. The new centre also includes an incoming laboratory, where all materials delivered are checked in accordance with the stringent Pfeiffer quality standards. This completes the quality circle, ensuring optimal efficiency from start to finish of the logistics chain. Drivers collecting goods from the plant also have automatic access to self-contained showering and rest facilities adjacent to the office area for the dispatch administration services. The technical centre will go into operation in August 2009 with its industrialisation and tooling services covering an area across 3,375 m² on two floors.
Building the future
Thomas Klofac, President of the Pfeiffer Pharma Division, explains that the current investment programme is geared to meeting growing demand, particularly for the new Pfeiffer ophthalmic products, electronic dispensing technology and systems for preservative-free substances. Extending the facilities in Eigeltingen also reconfirms the companys proven commitment to German engineering. He concludes, “Pfeiffer is committed to maintaining long-term relationships with employees, suppliers and customers. Our new facilities are proof of this commitment and our key to being able to react to market needs today and tomorrow.”